Thrombocytosis and Megakaryocytic Proliferation Are the Early Presentations in Patients With Jak2-Positive Myeloproliferative Neoplasm at age 50 or Younger With Clinical Follow-up and Cytogenetic Correlation
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.